• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

    26.50 +2.91 (+12.34%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,888,138
    Open 23.57
    Bid (Size) 26.52 (500)
    Ask (Size) 26.70 (100)
    Prev. Close 23.59
    Today's Range 23.57 - 26.50
    52wk Range 16.24 - 45.30
    Shares Outstanding 308,456,852
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Matthews Just Slashed Its Futu Position -- Here’s Why That Matters ↗
    Futu Holdings delivers digital brokerage and wealth management services to retail and institutional clients across Asia and global markets. 
    Via The Motley Fool
    News headline image
    Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
    Leading experts across cell therapy, oncology, and immunology will provide strategic input as Legend advances and expands beyond its current portfolio 
    From Legend Biotech USA Inc.
    Via GlobeNewswire

    Performance

    YTD
    +23.2%
    +23.2%
    1 Month
    +38.5%
    +38.5%
    3 Month
    +54.5%
    +54.5%
    6 Month
    -17.5%
    -17.5%
    1 Year
    -20.1%
    -20.1%

    More News

    Read More
    News headline image
    Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Why Legend Biotech Stock Crushed the Market on Monday ↗
    Via The Motley Fool
    Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q4 2025 Results, Beats on EPS ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 12, 2025 ↗
    Via Benzinga
    News headline image
    What to Expect from Legend Biotech's Earnings ↗
    Via Benzinga
    News headline image
    Legend Biotech (LEGN) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Legend Biotech (LEGN) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗
    Via The Motley Fool
    Topics Earnings Economy World Trade
    News headline image
    Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗
    Via The Motley Fool
    News headline image
    Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    These stocks are gapping in today's session ↗
    Via Chartmill
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy
    News headline image
    Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗
    Via The Motley Fool
    News headline image
    Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
    From Legend Biotech USA Inc.
    Via GlobeNewswire
    News headline image
    Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights
    From Legend Biotech USA Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Legend Biotech Corporation - American Depositary Shares publicly traded?
    Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.
    What exchange does Legend Biotech Corporation - American Depositary Shares trade on?
    Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?
    The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market
    What is the current price of Legend Biotech Corporation - American Depositary Shares?
    The current price of Legend Biotech Corporation - American Depositary Shares is 26.50
    When was Legend Biotech Corporation - American Depositary Shares last traded?
    The last trade of Legend Biotech Corporation - American Depositary Shares was at 05/04/26 04:00 PM ET
    What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?
    The market capitalization of Legend Biotech Corporation - American Depositary Shares is 8.17B
    How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?
    Legend Biotech Corporation - American Depositary Shares has 8B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.